Related Experiment Video
Updated: Jun 19, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Published on: October 23, 2019
A peptide biosensor for detecting intracellular Abl kinase activity using matrix-assisted laser desorption/ionization
Ekaterina A Placzek1, Michael P Plebanek, Andrew M Lipchik
1Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Center for Cancer Research, Purdue University, West Lafayette, IN 47904, USA.
Abstract:
Many cancers are characterized by changes in protein phosphorylation as a result of kinase dysregulation. Disruption of Abl kinase signaling through the Philadelphia chromosome (causing the Bcr-Abl mutation) in chronic myeloid leukemia (CML) has provided a paradigm for development of kinase inhibitor drugs such as the specific inhibitor imatinib (also known as STI571 or Gleevec). However, because patients are treated indefinitely with this drug to maintain remission, resistance is increasingly becoming an issue. Although there are many ways to detect kinase activity, most lack the ability to "multiplex" the analysis (i.e., to detect more than one substrate simultaneously). Here we report a novel biosensor for detecting Abl kinase activity and sensitivity to inhibitor in live intact cells overexpressing a CML model Abl kinase construct. This straightforward methodology could eventually provide a new tool for detecting kinase activity and inhibitor drug response in cancer cells that overexpress oncogenic kinases.
Insights
Researchers developed a novel biosensor to detect Abl kinase activity and drug response in cancer cells. This tool addresses limitations in multiplexing kinase activity detection and aids in understanding drug resistance mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Cancer often involves dysregulated kinase activity, exemplified by Bcr-Abl in chronic myeloid leukemia (CML).
- Kinase inhibitor drugs like imatinib are effective but face challenges with acquired resistance due to long-term use.
- Current methods for detecting kinase activity often lack multiplexing capabilities, limiting simultaneous substrate analysis.
Purpose of the Study:
- To develop a novel biosensor for detecting Abl kinase activity in live cells.
- To assess the sensitivity of Abl kinase activity to inhibitor drugs using the biosensor.
- To provide a new tool for analyzing oncogenic kinase activity and drug response.
Main Methods:
- Development of a novel biosensor system.
- Utilizing the biosensor to detect Abl kinase activity in live intact cells.
- Overexpressing a CML model Abl kinase construct in cells for testing.
Main Results:
- Successfully detected Abl kinase activity using the novel biosensor in live cells.
- Demonstrated the biosensor's capability to assess inhibitor sensitivity.
- The methodology proved effective in cells overexpressing a CML model Abl kinase.
Conclusions:
- The novel biosensor enables detection of Abl kinase activity and inhibitor response in intact cells.
- This straightforward methodology offers a potential new tool for cancer research.
- It could aid in understanding and overcoming drug resistance in cancers with oncogenic kinase overexpression.
Related Concept Videos
Matrix-Assisted Laser Desorption Ionization (MALDI)
MALDI-TOF Mass Spectrometry
Rapid Identification of Pathogens

